Skip to main
FNCH

FNCH P/E Ratio

P/E Ratio as of Mar 27, 2026: -1.04

Average-1.31
Median-1.45
Minimum-1.50
Maximum-0.8300
-1.04
0.46 (30.67%)past month
The P/E ratio for FNCH is -1.04 as of Mar 27, 2026. This represents a decrease of -30.67% compared to its 12-month average P/E ratio of -1.5. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Finch Therapeutics Group P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Finch Therapeutics Group’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Finch Therapeutics Group to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FNCH P/E Ratio Historic Data

DateStock priceP/E ratio
Dec 1, 2025$13.505-1.53
Nov 3, 2025$13.405-1.52
Oct 1, 2025$12.28-1.39
Sep 2, 2025$13.00-1.47
Aug 1, 2025$12.47-1.41
Jul 1, 2025$13.20-1.50
Jun 2, 2025$13.60-1.54
May 1, 2025$12.75-1.45
Apr 1, 2025$14.25-1.62
Mar 3, 2025$15.05-1.71
Feb 3, 2025$11.26-1.28
Jan 2, 2025$11.30-1.28

FNCH End of Year P/E Ratio

DateP/E ratioChange
2026-1.04-32.03%
2025-1.53+19.53%
2024-1.28+2,033.33%
2023-0.06-71.43%
2022-0.21-97.42%
2021-8.13

FAQs About Finch Therapeutics Group (FNCH) P/E ratio

The latest P/E ratio of FNCH is -1.04, as of Mar 27, 2026. This is calculated based on its current stock price and earnings per share (EPS).

Finch Therapeutics Group’s last 12-month average P/E ratio is -1.5, compared to its current P/E ratio of -1.04. This reflects a decrease of -30.67%.

Finch Therapeutics Group’s current P/E ratio of -1.04 is lower than its last 12-month average P/E of -1.5. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Finch Therapeutics Group’s average P/E ratio over the last 3 years is -0.83. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Finch Therapeutics Group’s average P/E ratio over the last 5 years is -1.23. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Finch Therapeutics Group (FNCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.